Key result
Renal sympathetic denervation and baroreflex sensitization represent novel device-based strategies for managing systemic hypertension.
Why the study?
Despite advances in hypertension treatment, adequate management and control remain poor, motivating development of novel procedure- and device-based strategies.
This review highlights renal sympathetic denervation and baroreflex sensitization as novel procedure- and device-based strategies for managing systemic hypertension.
Answers are grounded in this paper and cite their sources.
Novel hypertension therapies under review may address persistent control gaps; leaves open their efficacy in practice pending trials.
Despite the considerable advances in the treatment of hypertension that have been made over the past few decades, adequate management and control of this condition remains poor, and efforts are ongoing to develop new strategies to improve related outcomes. Novel therapeutic approaches to the management of systemic hypertension fall into two major categories: (i) those that seek to improve blood pressure-lowering efficacy using new therapeutic strategies in addition to standard non-pharmacological and pharmacological approaches and (ii) novel ways to optimize and improve the efficacy and utility of existing therapies. Novel procedure- and device-based strategies to control hypertension include renal sympathetic denervation and baroreflex sensitization. These two techniques will be the focus of the present review.
No takes yet. Share an insight, caveat, or question.
Krum et al. (2011) conducted a review in systemic hypertension. Renal sympathetic denervation and baroreflex sensitization was evaluated. Renal sympathetic denervation and baroreflex sensitization are novel procedure- and device-based strategies reviewed for the management of systemic hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: